Impressively, this combination also remarkably inhibited the pre-inflammatory mediators release of IL-6 and TNF-α, which provides a specific target in the screening of anti-inflammatory drugs for the treatment of schistosomiasis-induced liver fibrosis. This evidence concerns the gene IL6 and Hepatic fibrosis.